| abstract |
The present invention relates to HCV NS3 proteins and nucleic acids. In particularnsaid HCV NS3 combines major epitopes correlating with the control of HCVninfection. The HCV NS3 proteins and nucleic acids of the invention, or compositionsncomprising them are of use in prophylactic and therapeutic treatment of HCVninfection. Specifically, the HCV NS3 proteins and nucleic acids are used in thenpreparation of a vaccine composition for the prophylactic and therapeutic treatment ofnHCV. |